Thrombotic thrombocytopenic purpura and pregnancy: A case report and a review of the literature

Annals of Hematology

Volumn 81, Issue 4, 2002, Pages 210-214

  Proia, A ^a   Paesano, R ^a   Torcia, F ^a   Annino, L ^b   Capria, S ^a   Ferrari, A ^b   Ferrazza, G ^a   Pacifici, E ^a   Pantalissi, A ^a   Meloni, G ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b Umberto I Hospital   (Italy)

Author keywords

Pregnancy; Thrombotic thrombocytopenic purpura; Treatment

Indexed keywords

ACETYLSALICYLIC ACID; ANTIHYPERTENSIVE AGENT; CORTICOSTEROID; DEXAMETHASONE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; FRESH FROZEN PLASMA; GLUCOCORTICOID; LOW MOLECULAR WEIGHT HEPARIN; METHYLDOPA; METHYLPREDNISOLONE; PREDNISOLONE; PREDNISONE; SPIRAMYCIN; VINCRISTINE;

ADULT; ARTICLE; BLOOD PLACENTA BARRIER; CANCER; CASE REPORT; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEMATOLOGIC DISEASE; HUMAN; INFECTION; MATERNAL HYPERTENSION; MEDICAL LITERATURE; MORTALITY; OBSTETRIC CARE; PLASMA TRANSFUSION; PLASMAPHERESIS; PRIORITY JOURNAL; PUERPERIUM; RISK FACTOR; SIDE EFFECT; SURVIVAL RATE; THROMBOTIC THROMBOCYTOPENIC PURPURA; TOXOPLASMOSIS;

ADULT; ASPIRIN; DISEASE MANAGEMENT; FEMALE; HEPARIN; HUMANS; PRACTICE GUIDELINES; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; PURPURA, THROMBOTIC THROMBOCYTOPENIC; RECURRENCE; RISK FACTORS;

EID: 0036943735     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-001-0426-3     Document Type: Article

References (26)

1. Bukowski RM (1982) Thrombotic thrombocytopenic purpura: a review. Prog Haemostas Thromb 6:287-337
2. Ruggenenti P, Remuzzi G (1996) The pathophysiology and management of thrombotic thrombocytopenic purpura. Eur J Haematol 56:191-207
3. Kwaan HC, Soff GA (1997) Management of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Semin Hematol 34:159-166
4. Dervenoulas J, Tsirigotis P, Bollas G, Pappa V, Xiros N, Economopoulos T, Pappa M, Mellou S, Kostourou A, Papageorgious E, Raptis SA (2000) Thrombotic thrombocytopenic purpura/haemolytic uremic syndrome (TTP/HUS): treatment, outcome, relapses, prognostic factors. A single-center experience of 48 cases. Ann Hematol 79:66-72
5. Rock G, Porta C, Bobbio-Pallavicini E (2000) Thrombotic thrombocytopenic purpura treatment in year 2000. Haematologica 85:410-419
6. George JN (2000) How I treat patients with thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Blood 96:1223-1229
7. Tsai H-M, Lian EC-Y (1998) Antibodies to vonWillebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura. N Engl J Med 339:1585-1594
8. Furlan M, Robles R, Galbusera M, Remuzzi G, Kyrle PA, Brenner B, Krause M, Scharrer I, Aumann V, Mittler U, Solenthaler M, Lammle B (1998) Von Willebrand factor-cleaving protease in thrombotic thrombocytopenic purpura and the hemolytic-uremic syndrome. N Engl J Med 339:1578-1584
9. Ruggenenti P, Remuzzi G (1996) The pathophysiology and management of thrombotic thrombocytopenic purpura. Eur J Haematol 56:191-207
10. McCrae KR, Cines DB (1997) Thrombotic microangiopathy during pregnancy. Semin Hematol 34:148-158
11. Esplin MS, Branch DW (1999) Diagnosis and management of thrombotic microangiopathies during pregnancy. Clin Obstet Gynecol 42:360-367
12. Egerman RS, Sibai BM (1999) Imitators of preeclampsia and eclampsia. Clin Obstet Gynecol 42:551-562
13. D'Anna R, Mancuso A, Palmara V, Barbaro L, Leopardi R (1992) Antihypertensive drugs during pregnancy. Effects on the fetus. Minerva Ginecol 44:67-77
14. Khedun SM, Moodley J, Naicker T, Maharaj B (1997) Drug management of hypertensive disorders of pregnancy. Pharmacol Ther 74:221-258
15. Wechsler B, Huong Du LT, Piette JC (1999) Is there a role for antithrombotic therapy in the prevention of pregnancy loss? Haemostasis 29:112-120
16. Samama MM, Gerotziafas GT (2000) Comparative pharmacokinetics of LMWHs. Semin Thromb Hemost 26:31-38
17. Lubchenco IO (1970) Assessment of gestational age and development of birth. Pediatr Clin North Am 17:125-145
18. Weiner CP (1987) Thrombotic microangiopathy in pregnancy and in the postpartum period. Sem Hematol 24:119-129
19. Hayward CPM, Sutton DMC, Carter WH, Campbell ED, Scott JG, Francombe WH, Shumak KH, Baker MA (1994) Treatment outcomes in patients with adult thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Arch Intern Med 154:982-987
20. Egerman RS, Witlin AG, Friedman SA, Sibai BM (1996) Thrombotic thrombocytopenic purpura/hemolytic uremic syndrome in pregnancy: review of 11 cases. Am J Obstet Gynecol (SPO issue) 175:950-956
21. Ezra Y, Rose M, Eldor A (1996) Therapy and prevention of thrombotic thrombocytopenic purpura during pregnancy: a clinical study of 16 pregnancies. Am J Hematol 51:1-6
22. Dashe JS, Ramin SM, Cunningham FG (1998) The long-term consequences of thrombotic microangiopathy (thrombotic thrombocutopenic purpura and haemolytic uremic syndrome) in pregnancy. Obstet Gynecol 91:662-668
23. Porta C, Caporali R, Montecucco C (1999) Thrombotic thrombocytopenic purpura and autoimmunity: a tale of shadows and suspects. Haematologica 84:260-269
24. Spickett G (1999) Anti-phospholipid syndromes. Oxford handbook of clinical immunology. Oxford Medical Publications, Oxford
25. Petri M (2000) Treatment of the antiphospholipid antibody syndrome: progress in the last five years? Curr Rheumatol Rep 2:256-261
26. Ginsberg JS, Greer IA, Hirsh J (2001) Use of antithrombotic agents during pregnancy. Chest 119:122S-131S